* BioRestorative Therapies Inc BRTX.OQ BRTX.O is
expected
to show a rise in quarterly revenue when it reports results on
November 12 for the period ending September 30 2024
* The Melville New York-based company is expected to report
a
1,040.1% increase in revenue to $350 thousand from $30.7
thousand a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for BioRestorative Therapies
Inc
is for a loss of 43 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
BioRestorative
Therapies Inc is 12.00, above its last closing price of $1.56.
This summary was machine generated November 8 at 22:46 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)